Silybi mariani extractum siccum
Coated tablets
Read this leaflet carefully, as it contains important information for the patient.
This medicinal product is available without a prescription. However, to achieve the best treatment results, the medicinal product
Lagosa should be used cautiously.
Lagosa is a medicinal product that protects the liver from the effects of toxic compounds, stimulates its regenerative ability, prevents the penetration of hepatotoxic factors into liver cells, stabilizes and normalizes liver cell functions.
Indications for use:
Conditions after liver damage caused by toxic compounds; as a supportive treatment in chronic inflammatory liver conditions.
Do not use in case of hypersensitivity to the active or excipient substances contained in the product.
Use in children:
Due to the lack of safety data, use in children under 12 years of age is not recommended.
The medicinal product contains lactose and sucrose; if the patient has previously been diagnosed with intolerance to certain sugars, they should consult a doctor before taking the medicinal product.
No interactions with other medicinal products have been found.
Due to the lack of safety data, use during pregnancy and breastfeeding is not recommended.
No data available
Adults and children over 12 years: one coated tablet twice a day.
Tablets should be taken with a sufficient amount of liquid.
No cases of poisoning have been reported.
No antidote is known in case of overdose. Symptomatic treatment should be initiated.
Like all medicinal products, Lagosa can cause side effects, although they may not occur in every patient.
In case of side effects, use of the medicinal product should be stopped and medical advice sought.
Occasional mild laxative effect may occur.
If any side effects occur, including those not listed in the leaflet, the doctor, pharmacist, or nurse should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. Reporting of side effects will allow for the collection of more information on the safety of the medicinal product.
The medicinal product should be stored out of the reach and sight of children.
The medicinal product should not be used after the expiry date stated on the packaging. The expiry date refers to the last day of the given month.
No special precautions for storage are necessary.
Medicinal products should not be disposed of via wastewater or household waste. The pharmacist should be consulted on how to dispose of unused medicinal products. This will help protect the environment.
The active substance is 240.0 mg of dry extract of milk thistle (Frukt. Cardui mariae) equivalent to 150 mg of silymarin calculated as silybin.
Excipients:
Contains lactose and sucrose (see section 2).
The medicinal product is considered "sodium-free".
Round coated tablets.
Aluminium/PVC/PVDC foil blisters packaged in a cardboard box.
Packaging contains 25, 50, 100 coated tablets.
Not all pack sizes may be marketed.
WÖRWAG Pharma GmbH & Co. KG, Flugfeld-Allee 24, 71034 Böblingen, Germany
Dragenopharm Apotheker Püschl GmbH, Göllstrasse 1, 84529 Tittmoning, Germany. For more detailed information, please contact the representative of the marketing authorization holder: Woerwag Pharma Polska sp. z o.o., ul. Józefa Piusa Dziekońskiego 1, 00-728 Warsaw, tel. (+48) 22 863 72 81, fax (+48) 22 877 13 70
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.